Supported by extensive R&D activities and strong regulatory expertise, Fresenius Kabi’s generic IV drugs are developed to meet hospital needs and current healthcare trends. Our generic IV Drugs and associated packaging are developed in line with patient safety guidelines. User-friendly designs and colour differentiation are used for ease of product identification. Innovative packaging materials for Oncology drugs include the OncoShield™ sleeved vials offering maximum protection for healthcare professionals when handling cytotoxic drugs. Fresenius Kabi is committed to provide a reliable supply of high quality generic IV Drugs which are in line with current patient safety guidelines.